We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+9.6%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$72.7B
AUM Growth
+$7.54B
(+12%)
Cap. Flow
-$3.34B
Cap. Flow
% of AUM
-4.6%
Top 10 Holdings %
Top 10 Hldgs %
23.55%
Holding
2,585
New
253
Increased
940
Reduced
728
Closed
298
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crown Castle
CCI
|
+$536M |
| 2 |
Procter & Gamble
PG
|
+$358M |
| 3 |
CSX Corp
CSX
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$186M |
| 5 |
Eli Lilly
LLY
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$370M |
| 2 |
American Electric Power
AEP
|
+$338M |
| 3 |
Alibaba
BABA
|
+$322M |
| 4 |
Prologis
PLD
|
+$307M |
| 5 |
HEICO Corp
HEI
|
+$287M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.03% |
| 2 | Financials | 13.75% |
| 3 | Industrials | 12.1% |
| 4 | Healthcare | 10.45% |
| 5 | Consumer Discretionary | 7.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Zai Lab
ZLAB
$2.05B
| $73K | ﹤0.01% |
2,092
-139
| -6% | -$4.57K |
|
1727
iRhythm Holdings
IRTC
$4.1B
| $72K | ﹤0.01% |
+468
| New | +$60.5K |
|
1728
iShares 0-1 Year Treasury Bond ETF
SHV
$20.6B
| – | – |
0
| – | – |
|
1729
TG Therapeutics
TGTX
$7.07B
| $72K | ﹤0.01% |
2,027
-4,454
| -69% | -$166K |
|
|
TLN
1730
Talen Energy Corp
TLN
$16.3B
| $72K | ﹤0.01% |
248
| – | – |
|
1731
Sprinklr
CXM
$1.53B
| $71K | ﹤0.01% |
8,463
+8,135
| +2,480% | +$65.1K |
|
|
ARES.PRB
1732
Ares Management Corp 6.75% Series B Preferred Stock
ARES.PRB
$1.34B
| $71K | ﹤0.01% |
1,346
| – | – |
|
|
GOLD
1733
Gold.com Inc
GOLD
$1.24B
| $70K | ﹤0.01% |
3,192
+172
| +6% | +$3.82K |
|
1734
Celestica
CLS
$42.7B
| $70K | ﹤0.01% |
454
-413
| -48% | -$43.9K |
|
1735
iShares S&P 500 Growth ETF
IVW
$77.3B
| $70K | ﹤0.01% |
640
| – | – |
|
1736
Monro
MNRO
$399M
| $70K | ﹤0.01% |
+4,733
| New | +$68.2K |
|
1737
Quanex
NX
$883M
| $70K | ﹤0.01% |
3,749
-14,279
| -79% | -$253K |
|
1738
CPI Card Group
PMTS
$252M
| $69K | ﹤0.01% |
2,928
+1,467
| +100% | +$34.6K |
|
1739
CBIZ
CBZ
$2.99B
| $68K | ﹤0.01% |
960
+32
| +3% | +$2.31K |
|
1740
California Resources
CRC
$4.66B
| $68K | ﹤0.01% |
1,494
+6
| +0.4% | +$245 |
|
1741
DT Midstream
DTM
$13.8B
| $68K | ﹤0.01% |
621
+166
| +36% | +$16.8K |
|
1742
BlackLine
BL
$1.92B
| $67K | ﹤0.01% |
1,195
-288
| -19% | -$14.9K |
|
1743
Cytokinetics
CYTK
$10.4B
| $67K | ﹤0.01% |
2,055
-34,113
| -94% | -$1.19M |
|
1744
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.97B
| $67K | ﹤0.01% |
1,485
-1,466
| -50% | -$63.1K |
|
1745
Helen of Troy
HELE
$676M
| $67K | ﹤0.01% |
+2,368
| New | +$72.7K |
|
1746
Planet Fitness
PLNT
$4.45B
| $67K | ﹤0.01% |
617
-853
| -58% | -$85.4K |
|
1747
International Seaways
INSW
$4.71B
| $66K | ﹤0.01% |
1,811
-54,552
| -97% | -$1.96M |
|
1748
MDU Resources
MDU
$4.2B
| $66K | ﹤0.01% |
+4,014
| New | +$67.5K |
|
1749
Syndax Pharmaceuticals
SNDX
$1.69B
| $66K | ﹤0.01% |
+7,142
| New | +$78.6K |
|
1750
Harley-Davidson
HOG
$2.66B
| $65K | ﹤0.01% |
2,777
-22
| -0.8% | -$523 |
|
Similar funds
QCM
Lazard Asset Management's Q2 2025 Portfolio in Review
As of Q2 2025, Lazard Asset Management held 2,585 positions worth $72.7B, up 12% from $65.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Lazard Asset Management withdrew a net $3.34B in Q2 2025, closing 298 positions and reducing 728 holdings. Its most notable exit was Eastman Chemical, an estimated $13.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Industrials.
Against the trend, Lazard Asset Management opened a new position in Arcos Dorados Holdings worth $117M.
- Lazard Asset Management's largest Q2 2025 buy was Arcos Dorados Holdings: 14,873,278 shares worth $117M.
- Lazard Asset Management added most to Crown Castle in Q2 2025, an estimated $536M increase.
- Lazard Asset Management's biggest Q2 2025 reduction was NetEase, cutting an estimated $370M.
- Lazard Asset Management fully exited Eastman Chemical in Q2 2025, selling an estimated $13.1M.
- Lazard Asset Management's ten largest holdings make up 24% of its $72.7B portfolio in Q2 2025.
- Lazard Asset Management opened 253 new positions and closed 298 in Q2 2025.
- Lazard Asset Management's portfolio value rose 12% quarter-over-quarter to $72.7B.
Based on Lazard Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.